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Functional Expression of TRPC6 and TRPV4 Channels in Mouse Skeletal
Muscle Fibers
Yaxin Zhang, Bo Soelter, Heinrich Brinkmeier.
Institute of Pathophysiology, University of Greifswald, Greifswald,
Germany.
We have recently shown that the cation channels TRPC6 and TRPV4 are
expressed in mouse skeletal muscle and are at least partially localized in the
sarcolemma. However, little is known about their functions in skeletal muscle.
To investigate the role of TRPC6 and V4 for calcium influx into muscle fibers
we applied agonists and blockers of the above mentioned channels. ML-9,
known as a myosin light chain kinase inhibitor, is also a potent blocker of
TRPC6, but does not affect other TRP channels. 4a-PDD is known as
TRPV4 activator and HC-067047 was shown to be a specific TRPV4 inhibitor.
To investigate divalent cation influx we used single interosseus muscle fibers
and applied the Mn2þ quench technique using Fura-2. Quench of Fura-2 fluo-
rescence was measured in response to excitation at 360 nm in the presence
of 0.5 mM Mn2þ. OAG increased background calcium influx nearly twofold
(control vs. OAG; 3.3 50.3 vs. 6.550.6 %/min; n¼33; p<0.01), supporting
the view of functional expression of TRPC3 and/or C6 in skeletal muscle fibers.
This response was attenuated in the presence of 100 mM of ML-9 (OAG vs.
OAG and ML-9; 4.0 50.3 vs. 3.550.6 %/min; n¼36; not significant). ML-9
application to muscle fibers did not affect background calcium influx. Applica-
tion of the TRPV4 activator 4a-PDD (5 mM) caused an increase in background
calcium influx (control vs. 4a-PDD; 6.5 50.7 vs. 11.051.4 %/min; n¼33;
p<0.01). This increased calcium influx could be inhibited by 1 mM HC-
067047. We conclude that both channels, TRPC6 and TRPV4 are functional
in the sarcolemma of isolated mouse muscle fibers. Both channels do not
seem to have any resting activity but they can be pharmacologically activated
and blocked.
The work was supported by the Deutsche Duchenne Stiftung.
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Heteromeric TRPC3 with TRPC1 Formed via its Ankyrin Repeats
Regulates the Resting Cytosolic Ca2D Levels in Skeletal Muscle
Jin Seok Woo1, Keon Jin Lee1, Mei Huang1, Chung-Hyun Cho2,
Eun Hui Lee1.
1Dept. of Physiology, College of Medicine, The Catholic Univ. of Korea,
Seoul, Korea, Republic of, 2Dept. of Pharmacology, College of Medicine,
Seoul Nat’l Univ., Seoul, Korea, Republic of.
The main tasks of skeletal muscle are muscle contraction and relaxation, which
are mediated by changes in cytosolic Ca2þ levels. Canonical-type transient re-
ceptor potential 3 (TRPC3) contains an ankyrin repeat (AR) region at the N-ter-
minus (38-188 amino acids) and forms extracellular Ca2þ-entry channels by
homo or heteromerization with other TRP subtypes in various cells including
skeletal myotubes. However, previous research has not determined which
region(s) of TRPC3 is responsible for the heteromerization, whether the AR
region participates in the heteromerizations, or what is the role of heteromeric
TRPC3s in skeletal muscle. In the present study, the heteromerization of
TRPC3 with TRPC1 was first examined by GST pull-down assays of TRPC3
portions with TRPC1. The portion containing the AR region of TRPC3 was
bound to the TRPC1, but the binding was inhibited by the very end sub-
region of the TRPC3 (1-37 amino acids). In-silico studies have suggested
that the very end sub-region possibly induces a structural change in the AR
region. Second, the very end sub-region of TRPC3 was expressed in mouse
primary skeletal myotubes, resulting in a dominant-negative inhibition of het-
eromeric TRPC3/1 formation. In addition, the skeletal myotubes expressing the
very end sub-region showed a decrease in resting cytosolic Ca2þ levels. These
results suggest that the AR region of TRPC3 could mediate the heteromeric
TRPC3/1 formation, and the heteromeric TRPC3/1 could participate in regu-
lating the resting cytosolic Ca2þ levels in skeletal muscle.
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Identification of an Essential Structural Element of Lipid Gating Mecha-
nism in the Transient Receptor Potential Canonical Channel Type 3
(TRPC3)
Barbora Svobodova1, Michaela Lichtenegger1, Toma Glasnov2,
Thomas Stockner3, Dieter Platzer1, Michael Poteser1, Klaus Groschner1.
1Institute of Biophysics, Medical University of Graz, Graz, Austria, 2Institute
of Chemistry, University of Graz, Graz, Austria, 3Institute of Biophysics,
Medical University of Vienna, Vienna, Austria.
Transient receptor potential canonical 3 (TRPC3), is highly expressed in
neuronal and cardiac tissues, and its importance in development and (patho)physiology of these tissues is well established. So far, our understanding of
structure-function relations, specifically in terms of the lipid sensing machinery
in this channel protein is incomplete.
Using a homology model of TRPC3, based on the recently available structural
information on TRPV1, we performed structure-guided mutagenesis and iden-
tified a single residue within the transmembrane domain 6 (G652) as pivotal for
lipid-mediated gating of TRPC3. Increasing the residue size in position 652
eliminated lipid sensitivity. TRPC3G652A expressed in HEK293 cells was found
resistant to activation via the phospholipase C pathway or to direct adminis-
tration of diacylglycerols. On the contrary, a synthetic agonist of TRPC3/6/7
channels (GSK1702934A) activated both wild-type and TRPC3G652A channels,
generating even larger membrane conductances in the lipid-insensitive mutant.
To gain further insight into the mechanisms of TRPC3 activation by
GSK1702934A and diacylglycerols, we synthetized and characterized a series
of structurally related analogs of GSK1702934A. Our results identify two
groups of TRPC3 activators, one of which includes the putative physiological
activator diacylglycerol and is largely inactive in TRPC3G652A channels.
We suggest that lipid gating of TRPC3 strictly requires a hinge-point or a
certain level of flexibility within transmembrane segment S6 provided by
G652. Lipids and synthetic activators of TRPC3 may be capable of initiating
divergent gating movements in the channel.
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Ca2D and Calmodulin Regulation in Receptor-Operated Cation Currents
of TRPC6 Channels
Masayuki X. Mori1, Kyohei Itsuki2, Mitsuru Hirano1, Hideharu Hase1,
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1Engineering, Kyoto University, Kyoto, Japan, 2Dental science, Kyushu
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Calmodulin (CaM) contributes a variety of ion channels gating regulation
in response to Ca2þ changes. However, it is still missing the molecular basis
of CaM regulation in mammalian TRP channels which contribute to
receptor-operated cation (Ca2þ and Naþ) currents. To accumulate of Ca2þ
and CaM roles in TRP channels, we have firstly characterized the Ca2þ
regulation in TRPC6 channel, which is highly expressed in pulmonary
and vascular smooth muscle cells. The decay of the receptor-operated cation
currents of TRPC6 channels was clearly delayed to EGTA or BAPTA che-
lation, which suggested the global Ca2þ mechanism. We then examined
CaM binding to the C-terminal region of TRPC6 channels by using of
Ca2þ-dependent FRET system. FRET due to CaM binding to the C-terminal
region of TRPC6 channels demonstrated a bell-shape response curve to
Ca2þ increments, which was a unique pattern compared to the IQ-domain
of voltage-gated Ca and Na channels. And the bell-shape response curve
was altered to a simple grow curve by a mutation in either N- or C-globular
Ca2þ-binding domain (lobe) of CaM. Intriguingly, the mutant in the N-glob-
ular domain of CaM delayed the decay of receptor-operated currents of
TRPC6 channels, thus the lobe-specific function of CaM appeared in TRP
channels. These results indicated that the Ca2þ-dependent inactivation of
TRPC6 channels can be explain by the bell-shape response curve of CaM
binding which curve is probably caused by a conflictive binding between
the N- and C-globular domain of CaM to TRPC6 channels. Our results pro-
vide a unique molecular basis of CaM to terminate ion channel activity
which has critical roles in the down-stream of vasoconstrictors, transmitters
and growth factors.
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An Alternative Ion Permeation Pathway in the TRPM3a1 Isoform?
Katharina Held1, Annelies Janssens1, Stephan Philipp2, Thomas Voets1,
Joris Vriens1.
1KU Leuven, Leuven, Belgium, 2Universitaet des Saarlandes, Homburg,
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TRPM3 is a cation conducting ion channel that belongs to the superfamily of
transient receptor potential (TRP) channels. It is polymodally regulated by
stimuli including heat, hypoosmolarity, the endogenous agonist pregnenolone
sulphate (PS) as well as the synthetic agonist nifedipine. Recently, we have
shown that combined application of PS and the antifungal drug clotrimazole
(Clt) leads to the activation of TRPM3 by inducing the opening of two
pores, the central pore and an alternative ion permeation pathway. We have
further identified a selective activator of TRPM3, CIM0216, which is able
to open both pathways independently of the presence of other chemicals. At
the moment a tremendous amount of TRPM3 splice variants have been
described. In this study, we have selected one splice variant TRPM3a1, that dif-
fers from the TRPM3a2 isoform only in the presumed pore region. Remark-
ably, the TRPM3a1 isoform did not show any increase in channel activity
